Evotec SE (EVOTF) Return on Capital Employed (2021 - 2025)
Evotec SE's (EVOTF) quarterly Return on Capital Employed came in at 5.11% in Q4 2025, down 511.0% year-on-year from 1.24% in Q4 2024, and up 27.12% quarter-over-quarter from 7.02% in Q3 2025.
Evotec SE (EVOTF) Return on Capital Employed (2021 - 2025) Analysis & Trends
Evotec SE has disclosed Return on Capital Employed across 4 years of filings, most recently posting 5.11% for Q4 2025.
- Return on Capital Employed for Q4 2025 came in at 5.11%, down 511.0% year-over-year; the trailing twelve-month figure through Dec 2025 was 5.11% (down 511.0% YoY), and the FY2025 annual result was 0.01%, down 1.0% from the prior year.
- Return on Capital Employed came in at 5.11% for Q4 2025 at Evotec SE, up from 7.02% in the prior quarter.
- In the past five years, Return on Capital Employed ranged from a high of 0.0% in Q1 2022 to a low of 7.02% in Q3 2025.
- The 4-year median for Return on Capital Employed is 0.01% (2021), against an average of 2.03%.
- Across the five-year window, Return on Capital Employed grew 2 bps in 2022 and sank 511 bps in 2025, its largest moves.
- Evotec SE's Return on Capital Employed stood at 0.02% in 2021, then surged by 100 bps to 0.0% in 2022, then sank by 619 bps to 0.0% in 2024, then tumbled by 115270486 bps to 5.11% in 2025.
- The last three Return on Capital Employed figures came in at 5.11% (Q4 2025), 7.02% (Q3 2025), and 0.0% (Q4 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 8.52% |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 27.58% |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 21.43% |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 20.04% |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 7.34% |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 6.92% |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -1.92% |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 14.85% |
| 10 | Evotec SE | - | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -5.11% |
| Sep 30, 2025 | -7.02% |
| Dec 31, 2024 | 0.00% |
| Dec 31, 2022 | 0.00% |
| Mar 31, 2022 | 0.00% |
| Dec 31, 2021 | -0.02% |